LTRA Oral Preparations

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.470
Version
20210909
PublisherNHLBI Implementation Science and Health Care Innovation StewardDate2021-09-09T01:00:51-04:00Purpose

(Clinical Focus: This valueset includes oral leukotriene receptor antagonist preparations that are used for maintenance therapy in asthmatic adults and children as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007) and associated Summary Report and Quick Reference Guide and the 2020 Focused Updates to the Asthma Management Guidelines.),(Data Element Scope: FHIR MedicationStatement.medicationCodeableConcept, MedicationRequest.medicationCodeableConcept),(Inclusion Criteria: oral leukotriene receptor antagonists),(Exclusion Criteria: none)

Expansion
<<>>>
CodeDisplaySystem
311759http://www.nlm.nih.gov/research/umls/rxnorm
153893http://www.nlm.nih.gov/research/umls/rxnorm
404406http://www.nlm.nih.gov/research/umls/rxnorm
392072http://www.nlm.nih.gov/research/umls/rxnorm
199655http://www.nlm.nih.gov/research/umls/rxnorm
351246http://www.nlm.nih.gov/research/umls/rxnorm
153892http://www.nlm.nih.gov/research/umls/rxnorm
313758http://www.nlm.nih.gov/research/umls/rxnorm
200224http://www.nlm.nih.gov/research/umls/rxnorm
242438http://www.nlm.nih.gov/research/umls/rxnorm
261313http://www.nlm.nih.gov/research/umls/rxnorm
211776http://www.nlm.nih.gov/research/umls/rxnorm
391880http://www.nlm.nih.gov/research/umls/rxnorm
261367http://www.nlm.nih.gov/research/umls/rxnorm